CRYONOVE (EC14_4osc)
Sponsors
Cryonove Pharma
Conditions
LentigoPost Inflammatory HyperpigmentationSolar Lentigo
Unknown Phase
Evaluation of the Tolerance (Main Objective) and Performance of Cyto-selective Difluoroethane-based Cryotherapy in the Treatment of Brown Spots (Solar and Senile Lentigines, Post-inflammatory Hyperpigmentation) on the Face
Not yet recruitingNCT06305897
Start: 2024-04-30End: 2024-12-31Target: 45Updated: 2024-04-17
Interventional, Monocentric, Double-blind Randomized Category 2b Study Evaluating the Evaluation of the Tolerance of Cyto-selective Difluoroethane-based Cryotherapy in the Treatment of Brown Spots (Solar and Senile Lentigines, Post -Inflammatory Hyperpigmentation (Pih)) on the Face
CompletedNCT06361251
Start: 2024-09-16End: 2024-12-12Updated: 2024-12-24